2025 Year in Review
In 2025, Aniridia North America strengthened global connections, expanded patient education, and deepened research collaboration across the aniridia community. From hosting our international symposium to answering more than 100 patient…
ANA Announces Biennial Symposium
Aniridia North America (ANA) announces its biennial scientific event to strengthen and expand research focused on aniridia and related problems. The 2025 Aniridia North America Symposium: PAX6, Aniridia, and Beyond…
Peter A. Netland, MD, PhD appointed Chair of the Department of Ophthalmology at Eastern Virginia Medical School (EVMS) in Norfolk, VA
Aniridia North America (ANA) is pleased to announce that our Board Chair, Dr. Peter Netland, is moving to Eastern Virginia Medical School (EVMS) in Norfolk, Virginia as Professor and Chair of the Department of Ophthalmology.
2023 In Review & 2024 Strategic Plan
Thank you to all who supported and donated to ANA in 2023. Thanks to your support, great things were achieved! The ANA Board of Directors is looking forward to another great year in 2024.
The infographics below provide a snapshot of the accomplishments in 2023 and highlight some goals set for 2024.
Focal Point – Episode 3 – Aniridia 101: How to Care for a Child’s Eyes with Aniridia
ANA’s 3rd episode of Focal Point –Aniridia 101: How to Care for a Child’s Eyes with Aniridia– was held on August 22 with Guest: Dr. Alex Levin. View a recording here.
ANA to Host Biennial Scientific Symposium Dedicated to PAX6 and Aniridia
Charlottesville, VA – Aniridia North America (ANA) announces its biennial scientific event to strengthen and expand research focused on aniridia and related problems. The 2023 Aniridia North America Symposium: PAX6,…
“Report on the 2021 Aniridia North America symposium on PAX6, aniridia, and beyond”
ANA is pleased to announce that the article “Report on the 2021 Aniridia North America symposium on PAX6, aniridia, and beyond” has been published in July 2023 issue of The…
ANA Launches Patient and Family Advisory Board
ANA is pleased to announce the creation of a Patient and Family Advisory Board. The purpose of the ANA Patient and Family Advisory Board (PFAB) is to provide persons with aniridia…
“Visual Acuity in Aniridia and WAGR Syndrome”
An article was recently published in the journal Clinical Ophthalmology regarding a new study comparing the visual acuity in aniridia vs. WAGR syndrome. Here is a plain language summary of…
ANA Joins Global Genes & Formalizes Partnerships
ANA recognizes that, in the rare disease community, we are stronger when working together with those who share common goals. Recently, ANA acted upon this vision by joining Global Genes and formalizing partnerships with VFT and the IWSA.
